Eh, well, would not call "excellent." I have concerns about the editorial; it failed to mention a key finding, and the most statistically significant one, which (even though I like both the authors very much) is kind of dirty pool-ish. This is a treatment that Zietman abou 7 years ago called "a threat" to rad onc careers and pay! It's a loaded topic that few seem able to discuss dispassionately.
Re: LRFS vs LR, as I understand it... In a KM plot of LR, if a patient dies, they are censored and LR can never become a recordable event. With LRFS, death
or local recurrence are events. It does not seem like the "right way" to me to censor patients
tempus infinitum from local recurrence;
the TARGITists make a compelling argument IMHO.
Disclaimer: I have never done a TARGIT treatment. I am also not Jayant Vaidya!